Indian company partners with Nanogen to distribute Nano Covax vaccine

VOV.VN - Indian firm Vekaria Healthcare LLP and Nanogen Pharmaceutical Biotechnology JSC, the Vietnamese developer of Nano Covax vaccine against COVID-19 have signed a non-disclosure agreement (NDA) on the transfer of technology to produce the vaccine.

Signatories to the agreement were Yogendra Vekaria, managing director of Vekaria Healthcare LLP, and Ho Nhan, general director of Nanogen Pharmaceutical Biotechnology JSC.

The signing of the agreement is anticipated to provide the basis for future co-operation regarding the production and distribution of the Nano Covax vaccine on a mass scale.

Nano Covax is a locally-produced COVID-19 vaccine that has been researched and developed by Nanogen Pharmaceutical Biotechnology JSC. The Vietnamese vaccine is currently in its third phase of clinical trials and has so far yielded positive results.

At present, Nanogen has co-ordinated with relevant agencies aimed at speeding up the clinical trial process in order to receive permission for the vaccine to be used soon in Vietnam.

Addressing the signing ceremony, Vietnamese Ambassador to India Pham Sanh Chau affirmed that the co-operation programme between the two companies is of great significance, particularly in the context of the pandemic raging in India, Vietnam, and other nations globally.

The introduction of the Nano Covax vaccine into production and distribution will serve to greatly contribute to eradicating the pandemic in the near future,  Ambassador Chau noted.

Related

India to deliver 1 mln COVID-19 Remdesivir doses to Vietnam
India to deliver 1 mln COVID-19 Remdesivir doses to Vietnam

VOV.VN - Some of big Indian pharmaceutical companies have agreed to provide Vietnam with approximately 1 million doses of Remdesivir, a broad-spectrum antiviral medication, for COVID-19 treatment.

India to deliver 1 mln COVID-19 Remdesivir doses to Vietnam

India to deliver 1 mln COVID-19 Remdesivir doses to Vietnam

VOV.VN - Some of big Indian pharmaceutical companies have agreed to provide Vietnam with approximately 1 million doses of Remdesivir, a broad-spectrum antiviral medication, for COVID-19 treatment.

Vietnam receives 500,000 AstraZeneca vaccine doses from COVAX
Vietnam receives 500,000 AstraZeneca vaccine doses from COVAX

VOV.VN - Vietnam received an additional 494,400 doses of the AstraZeneca COVID-19 vaccine from the COVAX Facility on August 10, bringing the total number of its sponsored vaccines to over 9.1 million doses.

Vietnam receives 500,000 AstraZeneca vaccine doses from COVAX

Vietnam receives 500,000 AstraZeneca vaccine doses from COVAX

VOV.VN - Vietnam received an additional 494,400 doses of the AstraZeneca COVID-19 vaccine from the COVAX Facility on August 10, bringing the total number of its sponsored vaccines to over 9.1 million doses.